149 related articles for article (PubMed ID: 32917127)
1. Serum Kynurenines Correlate With Depressive Symptoms and Disability in Poststroke Patients: A Cross-sectional Study.
Carrillo-Mora P; Pérez-De la Cruz V; Estrada-Cortés B; Toussaint-González P; Martínez-Cortéz JA; Rodríguez-Barragán M; Quinzaños-Fresnedo J; Rangel-Caballero F; Gamboa-Coria G; Sánchez-Vázquez I; Barajas-Martínez K; Franyutti-Prado K; Sánchez-Chapul L; Ramírez-Ortega D; Ramos-Chávez LA
Neurorehabil Neural Repair; 2020 Oct; 34(10):936-944. PubMed ID: 32917127
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
[TBL] [Abstract][Full Text] [Related]
3. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
[TBL] [Abstract][Full Text] [Related]
4. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
5. Poststroke depression: prevalence and determinants in Brazilian stroke patients.
Carod-Artal FJ; Ferreira Coral L; Trizotto DS; Menezes Moreira C
Cerebrovasc Dis; 2009; 28(2):157-65. PubMed ID: 19556768
[TBL] [Abstract][Full Text] [Related]
6. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder.
Sakurai M; Yamamoto Y; Kanayama N; Hasegawa M; Mouri A; Takemura M; Matsunami H; Miyauchi T; Tokura T; Kimura H; Ito M; Umemura E; Boku AS; Nagashima W; Tonoike T; Kurita K; Ozaki N; Nabeshima T; Saito K
Sci Rep; 2020 Feb; 10(1):1961. PubMed ID: 32029791
[TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
Meier TB; Drevets WC; Teague TK; Wurfel BE; Mueller SC; Bodurka J; Dantzer R; Savitz J
Brain Behav Immun; 2018 Jan; 67():59-64. PubMed ID: 28867283
[TBL] [Abstract][Full Text] [Related]
8. Sleep disturbance and kynurenine metabolism in depression.
Cho HJ; Savitz J; Dantzer R; Teague TK; Drevets WC; Irwin MR
J Psychosom Res; 2017 Aug; 99():1-7. PubMed ID: 28712413
[TBL] [Abstract][Full Text] [Related]
9. Serum kynurenic acid is reduced in affective psychosis.
Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
[TBL] [Abstract][Full Text] [Related]
10. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
11. Effect of repetitive transcranial magnetic stimulation on the kynurenine pathway in stroke patients.
Niimi M; Ishima T; Hashimoto K; Hara T; Yamada N; Abo M
Neuroreport; 2020 Jun; 31(9):629-636. PubMed ID: 32427708
[TBL] [Abstract][Full Text] [Related]
12. Is poststroke depression a major depression?
da Rocha e Silva CE; Alves Brasil MA; Matos do Nascimento E; de Bragança Pereira B; André C
Cerebrovasc Dis; 2013; 35(4):385-91. PubMed ID: 23635428
[TBL] [Abstract][Full Text] [Related]
13. Poststroke depression and its multifactorial nature: results from a prospective longitudinal study.
De Ryck A; Fransen E; Brouns R; Geurden M; Peij D; Mariën P; De Deyn PP; Engelborghs S
J Neurol Sci; 2014 Dec; 347(1-2):159-66. PubMed ID: 25451004
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
[TBL] [Abstract][Full Text] [Related]
15. Differential Association of Serum BDNF With Poststroke Depression and Poststroke Anxiety.
Han Z; Wang Y; Qi L; Wang J; Wong J; Chen J; Luo X; Wang QM
Arch Phys Med Rehabil; 2020 Aug; 101(8):1355-1366. PubMed ID: 32416148
[TBL] [Abstract][Full Text] [Related]
16. Early Post-stroke Depressive Symptoms are Associated with Low Peripheral Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Glial Cell-derived Neurotrophic Factor (GDNF).
Pedroso VSP; Vieira ÉLM; de Miranda AS; Venna VR; McCullough LD; Teixeira AL
Curr Neurovasc Res; 2020; 17(4):495-501. PubMed ID: 32819258
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.
Aarsland TI; Landaas ET; Hegvik TA; Ulvik A; Halmøy A; Ueland PM; Haavik J
Behav Brain Funct; 2015 Nov; 11(1):36. PubMed ID: 26542774
[TBL] [Abstract][Full Text] [Related]
18. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
